(Q41859441)

English

Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials

scientific article published on December 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 October 2017

Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials (English)

1 reference

Europe PubMed Central

13 October 2017

0 references

11

object named as

Michel Komajda

1 reference

Europe PubMed Central

13 October 2017

1

object named as

Marco Metra

1 reference

Europe PubMed Central

13 October 2017

18

object named as

Karl Swedberg

1 reference

Europe PubMed Central

13 October 2017

Michał Tendera

19

object named as

Michal Tendera

1 reference

Europe PubMed Central

13 October 2017

William T Abraham

3

object named as

William T Abraham

1 reference

Europe PubMed Central

13 October 2017

6

object named as

Ramon Corbalan

1 reference

Europe PubMed Central

13 October 2017

author name string

Eric Eichhorn

2

1 reference

Europe PubMed Central

13 October 2017

Jennifer Linseman

4

1 reference

Europe PubMed Central

13 October 2017

Michael Böhm

5

1 reference

Europe PubMed Central

13 October 2017

David DeMets

7

1 reference

Europe PubMed Central

13 October 2017

Teresa De Marco

8

1 reference

Europe PubMed Central

13 October 2017

Uri Elkayam

9

1 reference

Europe PubMed Central

13 October 2017

Michael Gerber

10

1 reference

Europe PubMed Central

13 October 2017

Peter Liu

12

1 reference

Europe PubMed Central

13 October 2017

Vyacheslev Mareev

13

1 reference

Europe PubMed Central

13 October 2017

Sergio V Perrone

14

1 reference

Europe PubMed Central

13 October 2017

Philip Poole-Wilson

15

1 reference

Europe PubMed Central

13 October 2017

Ellen Roecker

16

1 reference

Europe PubMed Central

13 October 2017

Jennifer Stewart

17

1 reference

Europe PubMed Central

13 October 2017

Brian Wiens

20

1 reference

Europe PubMed Central

13 October 2017

Michael R Bristow

21

1 reference

Europe PubMed Central

13 October 2017

ESSENTIAL Investigators

22

1 reference

Europe PubMed Central

13 October 2017

publication date

1 December 2009

1 reference

Europe PubMed Central

13 October 2017

European Heart Journal

1 reference

Europe PubMed Central

13 October 2017

30

1 reference

Europe PubMed Central

13 October 2017

24

1 reference

Europe PubMed Central

13 October 2017

3015-3026

1 reference

Europe PubMed Central

13 October 2017

Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

5 June 2018

Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

5 June 2018

Mechanisms and models in heart failure: the biomechanical model and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

5 June 2018

Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

5 June 2018

Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

5 June 2018

Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

5 June 2018

Inotropes and beta-blockers: is there a need for new guidelines?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

5 June 2018

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

5 June 2018

Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

5 June 2018

The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

5 June 2018

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

5 June 2018

Rationale and design of the enoximone clinical trials program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

18 August 2018

Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

18 August 2018

The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

18 August 2018

Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

18 August 2018

Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

18 August 2018

Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

18 August 2018

Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

18 August 2018

Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

18 August 2018

Long-Term Trends in the Incidence of and Survival with Heart Failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792716

2 December 2018

Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19700774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19700774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19700774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maximal and submaximal exercise testing in heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19700774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Convert

1 reference

https://pubmed.ncbi.nlm.nih.gov/19700774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19700774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19700774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995

1 reference

https://pubmed.ncbi.nlm.nih.gov/19700774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/EURHEARTJ/EHP338

1 reference

Europe PubMed Central

13 October 2017

1 reference

Europe PubMed Central

13 October 2017

1 reference

Europe PubMed Central

13 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41859441&oldid=1785761860"